• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

径向入路可预防心导管检查术后对比剂诱导的肾病。

Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.

机构信息

Internal Medicine IV, University Hospital of Schleswig Holstein, Campus Kiel, Kiel, Germany.

Internal Medicine III, University Hospital of Schleswig Holstein, Campus Kiel, Rosalind-Franklin-Str.12, 24105, Kiel, Germany.

出版信息

Clin Res Cardiol. 2018 Feb;107(2):148-157. doi: 10.1007/s00392-017-1166-2. Epub 2017 Sep 22.

DOI:10.1007/s00392-017-1166-2
PMID:28939956
Abstract

OBJECTIVES

To assess, whether cardiac catheterization via radial access prevents contrast-induced nephropathy.

BACKGROUND

Contrast-induced nephropathy (CIN) is a major clinical problem which accounts for more than 10% of acute kidney injury cases in hospitalized patients. Protective measures such as the infusion of isotonic saline solution or acetylcysteine have not consistently been proven to prevent acute kidney injury (AKI). However, there is growing evidence that radial access for coronary angiography and coronary intervention is associated with a lower incidence of AKI compared to femoral access.

METHODS AND RESULTS

In a retrospective monocentric analysis, 2937 patients that had undergone cardiac catheterization were examined. Up to 2013, coronary intervention was performed primarily via the femoral artery in our hospital; thereafter, interventions were primarily done via the radial artery. In the cohort under study, 1141 patients had received catheterization using the radial access while 1796 were examined via the femoral artery. No significant differences were found in the two groups regarding the amount of iodinated contrast medium applied [femoral group: 180 (120-260) ml; radial group: 180 (120-250) ml; P = 0.438]. A total of 400 (13.6%) patients developed acute kidney injury (AKI) after cardiac catheterization (85.3% AKI stage 1; 12.8% AKI stage 2; 2% AKI stage 3). AKI was significantly less frequent in patients that had received radial access compared to patients with femoral access (10.1 vs. 15.9%, P < 0.001). Multivariate regression analysis showed that patient age (1.03/year; 95% CI 1.02-1.04/year; P < 0.001), the amount of contrast media applied (OR 1.003/ml; 95% CI 1.002-1.004/ml; P < 0.001), acute coronary syndrome (OR 2.01, 95% CI 1.52-2.66; P < 0.001), CKD (OR 1.62, 95% CI 1.50-1.70; P < 0.001), pre-existing heart failure (OR 1.27, 95% CI 1.00-1.42 P = 0.007), previous myocardial infarction (OR 1.34, 95% CI 1.15-1.49; P = 0.001), diabetes (OR 1.25, 95% CI 1.04-1.41; P = 0.020) and serum creatinine before the procedure (1.45/mg/dl; 95% CI 1.24-1.69/mg/dl; P < 0.001) were important risk factors for the occurrence of AKI. Our analysis points to a significant risk reduction using radial access (OR 0.65; 95% CI 0.51-0.83; P < 0.001). Interestingly, this reduction in risk was also evident in patients with CKD (OR 0.59; 95% CI 0.41-0.87; P = 0.007). The superiority of radial access was particularly obvious in the subgroup of patients with acute coronary syndrome (13.1% AKI in the radial access group vs. 23.6% AKI in the femoral access group, OR 0.52; 95% CI 0.34-0.81; P = 0.003).

CONCLUSION

Our study shows that cardiac catheterization using radial access bears significantly lower risk of AKI than cardiac catheterization via femoral access. The advantage of radial access in acute coronary syndrome regarding morbidity and mortality could partly be explained by the here demonstrated reduced risk for AKI. Thus, radial access should be preferred in patients at risk for AKI.

摘要

目的

评估经桡动脉入路行心脏导管检查是否能预防造影剂肾病。

背景

造影剂肾病(CIN)是一个主要的临床问题,占住院患者急性肾损伤病例的 10%以上。虽然有保护措施,如输注等渗盐水或乙酰半胱氨酸,但尚未一致证明这些措施能预防急性肾损伤(AKI)。然而,越来越多的证据表明,与股动脉入路相比,经冠状动脉造影和冠状动脉介入治疗的桡动脉入路与较低的 AKI 发生率相关。

方法和结果

在一项回顾性单中心分析中,检查了 2937 例接受心脏导管检查的患者。直到 2013 年,我们医院的冠状动脉介入治疗主要通过股动脉进行;此后,干预主要通过桡动脉进行。在研究队列中,1141 例患者接受了桡动脉入路的导管检查,1796 例患者通过股动脉进行了检查。两组间应用的碘造影剂量无显著差异[股动脉组:180(120-260)ml;桡动脉组:180(120-250)ml;P=0.438]。心脏导管检查后共有 400(13.6%)例患者发生急性肾损伤(AKI)(85.3% AKI 第 1 期;12.8% AKI 第 2 期;2% AKI 第 3 期)。与股动脉入路患者相比,桡动脉入路患者 AKI 发生率显著降低(10.1%比 15.9%,P<0.001)。多变量回归分析显示,患者年龄(每增加 1 岁:1.03/年;95%CI 1.02-1.04/年;P<0.001)、应用造影剂量(OR 1.003/ml;95%CI 1.002-1.004/ml;P<0.001)、急性冠状动脉综合征(OR 2.01,95%CI 1.52-2.66;P<0.001)、慢性肾脏病(OR 1.62,95%CI 1.50-1.70;P<0.001)、预先存在的心力衰竭(OR 1.27,95%CI 1.00-1.42,P=0.007)、既往心肌梗死(OR 1.34,95%CI 1.15-1.49;P=0.001)、糖尿病(OR 1.25,95%CI 1.04-1.41;P=0.020)和手术前的血清肌酐(1.45/mg/dl;95%CI 1.24-1.69/mg/dl;P<0.001)是 AKI 发生的重要危险因素。我们的分析表明,使用桡动脉入路显著降低了风险(OR 0.65;95%CI 0.51-0.83;P<0.001)。有趣的是,在慢性肾脏病患者中,这种风险的降低也很明显(OR 0.59;95%CI 0.41-0.87;P=0.007)。桡动脉入路的优越性在急性冠状动脉综合征患者亚组中尤为明显(桡动脉组 AKI 发生率为 13.1%,股动脉组 AKI 发生率为 23.6%,OR 0.52;95%CI 0.34-0.81;P=0.003)。

结论

本研究表明,与股动脉入路相比,经桡动脉入路行心脏导管检查发生 AKI 的风险显著降低。桡动脉入路在急性冠状动脉综合征患者中的优势在发病率和死亡率方面可能部分归因于这里证明的 AKI 风险降低。因此,在有 AKI 风险的患者中,应优先选择桡动脉入路。

相似文献

1
Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.径向入路可预防心导管检查术后对比剂诱导的肾病。
Clin Res Cardiol. 2018 Feb;107(2):148-157. doi: 10.1007/s00392-017-1166-2. Epub 2017 Sep 22.
2
Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.在接受ST段抬高型心肌梗死直接经皮冠状动脉介入治疗的患者中,桡动脉与股动脉入路与对比剂诱导的急性肾损伤的相关性。
Cardiovasc Revasc Med. 2016 Dec;17(8):546-551. doi: 10.1016/j.carrev.2016.07.008. Epub 2016 Jul 21.
3
Radial vs femoral access for the prevention of acute kidney injury (AKI) after coronary angiography or intervention: A systematic review and meta-analysis.经桡动脉与股动脉入路对冠状动脉造影或介入术后急性肾损伤(AKI)预防的系统评价与荟萃分析。
Catheter Cardiovasc Interv. 2018 Dec 1;92(7):E518-E526. doi: 10.1002/ccd.27903. Epub 2018 Sep 23.
4
Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.经皮冠状动脉介入治疗后急性肾损伤:AKI-MATRIX(通过桡动脉穿刺部位及血管造影X系统全面应用减少急性肾损伤不良出血事件)子研究的原理
Catheter Cardiovasc Interv. 2015 Nov;86(5):950-7. doi: 10.1002/ccd.25932. Epub 2015 Apr 9.
5
Impact of vascular access on acute kidney injury after percutaneous coronary intervention.血管通路对经皮冠状动脉介入治疗后急性肾损伤的影响。
Cardiovasc Revasc Med. 2016 Jul-Aug;17(5):333-8. doi: 10.1016/j.carrev.2016.03.004. Epub 2016 Mar 10.
6
Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.血管通路对行冠状动脉造影和/或经皮冠状动脉介入治疗的患者对比剂肾病发展的影响。
Int J Cardiol. 2019 Jan 15;275:48-52. doi: 10.1016/j.ijcard.2018.08.026. Epub 2018 Aug 10.
7
[Impact of femoral or radial approach on acute renal injury induced by repeated contrast medium in patients with coronary heart disease].[股动脉或桡动脉入路对冠心病患者反复使用造影剂所致急性肾损伤的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Dec 24;48(12):1053-1059. doi: 10.3760/cma.j.cn112148-20201105-00882.
8
Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).炎症与早期大剂量瑞舒伐他汀对急性冠脉综合征患者对比剂肾病获益的关系:PRATO-ACS 研究中的病理生理学联系(瑞舒伐他汀和抗血小板治疗对接受经皮冠状动脉介入治疗的急性冠脉综合征患者对比剂肾病和心肌损伤的保护作用)。
JACC Cardiovasc Interv. 2014 Dec;7(12):1421-9. doi: 10.1016/j.jcin.2014.06.023.
9
Impact of Radial Access on Contrast-Induced Acute Kidney Injury in Patients With Coronary Artery Bypass Grafts.经桡动脉入路对冠状动脉旁路移植术患者对比剂诱导急性肾损伤的影响。
Cardiovasc Revasc Med. 2022 Mar;36:123-131. doi: 10.1016/j.carrev.2021.04.026. Epub 2021 Apr 28.
10
Effect of Access Site Choice on Acute Kidney Injury After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后穿刺部位选择对急性肾损伤的影响
Am J Cardiol. 2017 Dec 15;120(12):2141-2145. doi: 10.1016/j.amjcard.2017.08.039. Epub 2017 Sep 20.

引用本文的文献

1
Acute Kidney Injury in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: The Role of Vascular Access Site.接受经皮冠状动脉介入治疗的急性心肌梗死患者的急性肾损伤:血管入路部位的作用
J Clin Med. 2024 Apr 18;13(8):2367. doi: 10.3390/jcm13082367.
2
Data analytics approach for short- and long-term mortality prediction following acute non-ST-elevation myocardial infarction (NSTEMI) and Unstable Angina (UA) in Asians.亚洲人群急性非 ST 段抬高型心肌梗死(NSTEMI)和不稳定型心绞痛(UA)后短期和长期死亡率的数据分析方法。
PLoS One. 2024 Feb 15;19(2):e0298036. doi: 10.1371/journal.pone.0298036. eCollection 2024.
3

本文引用的文献

1
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX.经桡动脉或股动脉途径进行有创急性冠状动脉综合征治疗后的急性肾损伤:AKI-MATRIX研究。
J Am Coll Cardiol. 2017 May 11. doi: 10.1016/j.jacc.2017.02.070.
2
Contrast use in relation to the arterial access site for percutaneous coronary intervention: A comprehensive meta-analysis of randomized trials.经皮冠状动脉介入治疗中与动脉穿刺部位相关的造影剂使用:随机试验的综合荟萃分析。
World J Cardiol. 2017 Apr 26;9(4):378-383. doi: 10.4330/wjc.v9.i4.378.
3
Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End-Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization-An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program.
Standardized angiographic projections allow evaluation of coronary artery side branches with quantitative flow ratio (QFR).
标准化血管造影投影允许使用定量血流比(QFR)评估冠状动脉侧支。
Int J Cardiol Heart Vasc. 2024 Jan 29;50:101349. doi: 10.1016/j.ijcha.2024.101349. eCollection 2024 Feb.
4
Association of the classification and severity of heart failure with the incidence of contrast-induced acute kidney injury.心力衰竭的分类和严重程度与对比剂诱导的急性肾损伤的发生率之间的关联。
Sci Rep. 2021 Jul 28;11(1):15348. doi: 10.1038/s41598-021-94910-1.
5
[Contrast medium-induced acute kidney injury-Consensus paper of the working group "Heart and Kidney" of the German Cardiac Society and the German Society of Nephrology].[造影剂诱导的急性肾损伤——德国心脏病学会和德国肾脏病学会“心脏与肾脏”工作组共识文件]
Internist (Berl). 2021 Jan;62(1):111-120. doi: 10.1007/s00108-020-00938-2.
6
Comparison of acute kidney injury with radial vs. femoral access for patients undergoing coronary catheterization: An updated meta-analysis of 46,816 patients.冠状动脉导管插入术患者经桡动脉与股动脉入路急性肾损伤的比较:对46,816例患者的最新荟萃分析
Exp Ther Med. 2020 Nov;20(5):42. doi: 10.3892/etm.2020.9170. Epub 2020 Sep 2.
7
Kidney injury as post-interventional complication of TAVI.经导管主动脉瓣置换术(TAVI)后的介入并发症导致的肾损伤。
Clin Res Cardiol. 2021 Mar;110(3):313-322. doi: 10.1007/s00392-020-01732-8. Epub 2020 Aug 25.
8
Incidence, predictors, and relevance of acute kidney injury in patients undergoing left atrial appendage closure with Amplatzer occluders: a multicentre observational study.采用 Amplatzer 封堵器行左心耳封堵术患者的急性肾损伤发生率、预测因素及相关性:一项多中心观察性研究。
Clin Res Cardiol. 2020 Apr;109(4):444-453. doi: 10.1007/s00392-019-01524-9. Epub 2019 Jul 5.
9
Validation of National Cardiovascular Data Registry risk models for mortality, bleeding and acute kidney injury in interventional cardiology at a German Heart Center.德国心脏中心验证国家心血管数据注册风险模型在介入心脏病学中的死亡率、出血和急性肾损伤。
Clin Res Cardiol. 2020 Feb;109(2):235-245. doi: 10.1007/s00392-019-01506-x. Epub 2019 Jun 24.
10
Acute Kidney Injury Post Cardiac Catheterization: Does Vascular Access Route Matter?心脏导管插入术后急性肾损伤:血管通路途径重要吗?
Curr Cardiol Rev. 2019;15(2):96-101. doi: 10.2174/1573403X14666181113112210.
经桡动脉与经股动脉心脏导管插入术患者慢性肾脏病与输血率及进展至终末期肾病的关联——来自退伍军人事务部临床评估报告与追踪(CART)项目的分析
J Am Heart Assoc. 2017 Apr 18;6(4):e004819. doi: 10.1161/JAHA.116.004819.
4
Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.预防性水化以保护高危对比剂肾病(AMACING)患者的肾功能免受血管内碘造影剂影响:一项前瞻性、随机、3 期、对照、开放标签、非劣效性试验。
Lancet. 2017 Apr 1;389(10076):1312-1322. doi: 10.1016/S0140-6736(17)30057-0. Epub 2017 Feb 21.
5
Understanding and preventing contrast-induced acute kidney injury.理解并预防对比剂诱导的急性肾损伤。
Nat Rev Nephrol. 2017 Mar;13(3):169-180. doi: 10.1038/nrneph.2016.196. Epub 2017 Jan 31.
6
Estimating the Risk of Radiocontrast-Associated Nephropathy.评估放射性造影剂相关性肾病的风险。
J Am Soc Nephrol. 2017 Feb;28(2):653-659. doi: 10.1681/ASN.2016010021. Epub 2016 Sep 29.
7
Comorbid renal tubular damage and hypoalbuminemia exacerbate cardiac prognosis in patients with chronic heart failure.合并肾小管损伤和低白蛋白血症会加重慢性心力衰竭患者的心脏预后。
Clin Res Cardiol. 2016 Feb;105(2):162-71. doi: 10.1007/s00392-015-0899-z. Epub 2015 Jul 29.
8
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial.经皮冠状动脉介入治疗的急性冠状动脉综合征患者中桡动脉与股动脉入路的随机多中心试验。
Lancet. 2015 Jun 20;385(9986):2465-76. doi: 10.1016/S0140-6736(15)60292-6. Epub 2015 Mar 16.
9
Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons.德国心力衰竭的发病率、患病率和 1 年全因死亡率:一项基于超过 600 万人电子医疗保健数据的研究。
Clin Res Cardiol. 2015 Aug;104(8):688-96. doi: 10.1007/s00392-015-0841-4. Epub 2015 Mar 17.
10
Contrast induced nephropathy has to be differentiated from kidney injury due to atheroembolic disease.对比剂肾病必须与动脉粥样硬化栓塞性疾病所致的肾损伤相鉴别。
J Renal Inj Prev. 2013 Sep 1;2(3):107-8. doi: 10.12861/jrip.2013.34. eCollection 2013.